首页 / 业务领域 / Company News
The 2024 Year-End Summary | 【Chihe Group】Discovery Pharma
Reading frequency:38  Updated on:2025-02-08

Daily management

     

In 2024, Discovery Pharma achieved excellent results across various departments. In terms of corporate management, the company improved daily management, safety, environmental protection, occupational health, and other regulations, while also establishing a Government Affairs Department and a Project Management Department.


Achievements and Honors

In 2024, the company was awarded the titles of "Innovative Small and Medium-sized Enterprise" and "Hebei Province Biotech and Health Field Entrusted R&D Service Platform Recognition," and also passed the "ISO9001" quality management system certification. In terms of projects, the Shijiazhuang Chemical Pharmaceutical team completed the registration filings for 11 projects, with 2 still in the filing process, 7 completing process validation, and 5 currently under research.







Audit and Inspection

The company has successfully welcomed audits from leaders at various departmental levels and completed 4 B-certification expansion inspections. Thanks to the efforts of both the group and all company employees, Discovery Pharma (Shijiazhuang) successfully achieved its initial goals for the year, contributing to the group's rapid development.




Discovery Pharma



   

Discovery Pharma, located in the High-tech Zone of Shijiazhuang, Hebei, was established in 2019. It is a comprehensive, integrated platform offering generic and innovative drug research and development, as well as technology transfer services. The company adheres to the philosophy of "innovation drives development, and cooperation achieves win-win outcomes." With a customer-centric approach, it focuses on services such as chemical generic drug research and development, consistency evaluation technical services, MAH cooperation, research on modified new drugs, molecular synthesis technology, and drug registration consulting. Discovery Pharma provides high-quality pharmaceutical technology research and development services to pharmaceutical partners, helping them improve R&D efficiency and accelerate the transformation towards efficient commercialization and development.




PREV: Chihealbio Year-End Review | Reflecting to Start Better!
NEXT: 2024 Year-End Summary |【Chiheal Group】Chiheal Aikang Pharma
Copyright 2024 Nanjing Chiheal Bio Medicine Technology Co..Ltd All rights reserved.